{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:19:07Z","timestamp":1783556347296,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72676-2","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T18:06:25Z","timestamp":1777917985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hierarchical dynamic model for risk-stratified screening of nasopharyngeal carcinoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Lei","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0447-0221","authenticated-orcid":false,"given":"Xuewei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biaohua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenle","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fugui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyun","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4727-2858","authenticated-orcid":false,"given":"Mingfang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6286-6227","authenticated-orcid":false,"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7377-382X","authenticated-orcid":false,"given":"Shuixing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"72676_CR1","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","volume":"15","author":"ET Chang","year":"2006","unstructured":"Chang, E. T. & Adami, H. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomark. Prev. 15, 1765\u20131777 (2006).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"72676_CR2","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"Ca Cancer J. Clin."},{"key":"72676_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2016.01.040","volume":"374","author":"L Tang","year":"2016","unstructured":"Tang, L. et al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 374, 22\u201330 (2016).","journal-title":"Cancer Lett."},{"key":"72676_CR4","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1158\/1055-9965.EPI-20-1702","volume":"30","author":"ET Chang","year":"2021","unstructured":"Chang, E. T. et al. The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomark. Prev. 30, 1035\u20131047 (2021).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"72676_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.radonc.2010.05.022","volume":"97","author":"F Fang","year":"2010","unstructured":"Fang, F. et al. Multivariate analysis of quality of life outcome for nasopharyngeal carcinoma patients after treatment. Radiother. Oncol. 97, 263\u2013269 (2010).","journal-title":"Radiother. Oncol."},{"key":"72676_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","volume":"16","author":"P Blanchard","year":"2015","unstructured":"Blanchard, P. et al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the mac-npc meta-analysis. Lancet Oncol. 16, 645\u2013655 (2015).","journal-title":"Lancet Oncol."},{"key":"72676_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Nasopharyngeal carcinoma. Lancet 394, 64\u201380 (2019).","journal-title":"Lancet"},{"key":"72676_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/ng932","volume":"31","author":"B Feng","year":"2002","unstructured":"Feng, B. et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat. Genet 31, 395\u2013399 (2002).","journal-title":"Nat. Genet"},{"key":"72676_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1044579X02000883","volume":"12","author":"K Lo","year":"2002","unstructured":"Lo, K. & Huang, D. P. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin. Cancer Biol. 12, 451\u2013462 (2002).","journal-title":"Semin. Cancer Biol."},{"key":"72676_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2174\/156652409788970698","volume":"9","author":"X Li","year":"2009","unstructured":"Li, X. et al. Hla associations with nasopharyngeal carcinoma. Curr. Mol. Med. 9, 751\u2013765 (2009).","journal-title":"Curr. Mol. Med."},{"key":"72676_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/ijc.2910590502","volume":"59","author":"HP Lee","year":"1994","unstructured":"Lee, H. P. et al. Preserved foods and nasopharyngeal carcinoma: a case-control study among Singapore Chinese. Int. J. Cancer 59, 585\u2013590 (1994).","journal-title":"Int. J. Cancer"},{"key":"72676_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<358::AID-IJC11>3.0.CO;2-E","volume":"85","author":"JM Yuan","year":"2000","unstructured":"Yuan, J. M. et al. Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int. J. Cancer 85, 358\u2013363 (2000).","journal-title":"Int. J. Cancer"},{"key":"72676_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ijc.2910280308","volume":"28","author":"AP Lanier","year":"1981","unstructured":"Lanier, A. P. et al. Association of Epstein-Barr virus with nasopharyngeal carcinoma in Alaskan native patients: serum antibodies and tissue EBNA and DNA. Int. J. Cancer 28, 301\u2013305 (1981).","journal-title":"Int. J. Cancer"},{"key":"72676_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/mp.53.5.248","volume":"53","author":"G Niedobitek","year":"2000","unstructured":"Niedobitek, G. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol. Pathol. 53, 248\u2013254 (2000).","journal-title":"Mol. Pathol."},{"key":"72676_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/000348940211100304","volume":"111","author":"G Plaza","year":"2002","unstructured":"Plaza, G. et al. Association of Epstein-Barr virus and nasopharyngeal carcinoma in caucasian patients. Ann. Otol. Rhinol. Laryngol. 111, 210\u2013216 (2002).","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"72676_CR16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/ijc.32992","volume":"147","author":"W Tian","year":"2020","unstructured":"Tian, W. et al. Multiple low-frequency and rare HLA-B allelic variants are associated with reduced risk in 1,105 nasopharyngeal carcinoma patients in Hunan province, southern China. Int. J. Cancer 147, 1397\u20131404 (2020).","journal-title":"Int. J. Cancer"},{"key":"72676_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s42003-020-01487-y","volume":"3","author":"L Ning","year":"2020","unstructured":"Ning, L. et al. Nasopharyngeal carcinoma MHC region deep sequencing identifies HLA and novel non-HLA trim31 and trim39 loci. Commun. Biol. 3, 759 (2020).","journal-title":"Commun. Biol."},{"key":"72676_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00405-016-4236-6","volume":"274","author":"K Yao","year":"2017","unstructured":"Yao, K. et al. Cyp2e1 polymorphisms and nasopharyngeal carcinoma risk: a meta-analysis. Eur. Arch. Otorhinolaryngol. 274, 253\u2013259 (2017).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"72676_CR19","doi-asserted-by":"publisher","first-page":"e11852","DOI":"10.1097\/MD.0000000000011852","volume":"97","author":"J Lin","year":"2018","unstructured":"Lin, J. et al. Association between XRCC1 single-nucleotide polymorphisms and susceptibility to nasopharyngeal carcinoma: an update meta-analysis. Medicine 97, e11852 (2018).","journal-title":"Medicine"},{"key":"72676_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1470-2045(09)70326-2","volume":"10","author":"B Secretan","year":"2009","unstructured":"Secretan, B. et al. A review of human carcinogens-part e: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 10, 1033\u20131034 (2009).","journal-title":"Lancet Oncol."},{"key":"72676_CR21","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/jn\/nxz095","volume":"149","author":"D Barrett","year":"2019","unstructured":"Barrett, D. et al. Past and recent salted fish and preserved food intakes are weakly associated with nasopharyngeal carcinoma risk in adults in southern China. J. Nutr. 149, 1596\u20131605 (2019).","journal-title":"J. Nutr."},{"key":"72676_CR22","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/ije\/dyab060","volume":"50","author":"JH Lin","year":"2021","unstructured":"Lin, J. H. et al. Smoking and nasopharyngeal cancer: individual data meta-analysis of six prospective studies on 334 935 men. Int. J. Epidemiol. 50, 975\u2013986 (2021).","journal-title":"Int. J. Epidemiol."},{"key":"72676_CR23","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/aje\/kwx018","volume":"185","author":"ET Chang","year":"2017","unstructured":"Chang, E. T. et al. Active and passive smoking and risk of nasopharyngeal carcinoma: a population-based case-control study in southern China. Am. J. Epidemiol. 185, 1272\u20131280 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"72676_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0140-6736(64)92354-2","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein, M. A. & Barr, Y. M. Cultivation in vitro of human lymphoblasts from Burkitt\u2019s malignant lymphoma. Lancet 1, 252\u2013253 (1964).","journal-title":"Lancet"},{"key":"72676_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nm830","volume":"9","author":"SM Tugizov","year":"2003","unstructured":"Tugizov, S. M., Berline, J. W. & Palefsky, J. M. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat. Med. 9, 307\u2013314 (2003).","journal-title":"Nat. Med."},{"key":"72676_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","volume":"102","author":"SK Dunmire","year":"2018","unstructured":"Dunmire, S. K., Verghese, P. S. & Balfour, H. H. J. Primary Epstein-Barr virus infection. J. Clin. Virol. 102, 84\u201392 (2018).","journal-title":"J. Clin. Virol."},{"key":"72676_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104357","volume":"86","author":"L Ka-Yue Chow","year":"2022","unstructured":"Ka-Yue Chow, L. et al. Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma. Ebiomedicine 86, 104357 (2022).","journal-title":"Ebiomedicine"},{"key":"72676_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.2910170102","volume":"17","author":"G Henle","year":"1976","unstructured":"Henle, G. & Henle, W. Epstein-Barr virus-specific iga serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer 17, 1\u20137 (1976).","journal-title":"Int. J. Cancer"},{"key":"72676_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/bjc.1978.54","volume":"37","author":"HC Ho","year":"1978","unstructured":"Ho, H. C., Ng, M. H. & Kwan, H. C. Factors affecting serum iga antibody to epstein-barr viral capsid antigens in nasopharyngeal carcinoma. Br. J. Cancer 37, 356\u2013362 (1978).","journal-title":"Br. J. Cancer"},{"key":"72676_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ijc.1641","volume":"97","author":"W Cheng","year":"2002","unstructured":"Cheng, W. et al. Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int. J. Cancer 97, 489\u2013492 (2002).","journal-title":"Int. J. Cancer"},{"key":"72676_CR31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/aje\/kwu176","volume":"180","author":"AE Coghill","year":"2014","unstructured":"Coghill, A. E. & Hildesheim, A. Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature. Am. J. Epidemiol. 180, 687\u2013695 (2014).","journal-title":"Am. J. Epidemiol."},{"key":"72676_CR32","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/jnci\/djaa198","volume":"113","author":"JA Miller","year":"2021","unstructured":"Miller, J. A. et al. Cost-effectiveness of nasopharyngeal carcinoma screening with Epstein-Barr virus polymerase chain reaction or serology in high-incidence populations worldwide. J. Natl. Cancer Inst. 113, 852\u2013862 (2021).","journal-title":"J. Natl. Cancer Inst."},{"key":"72676_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4149\/neo_2016_013","volume":"63","author":"MJ Svajdler","year":"2016","unstructured":"Svajdler, M. J. et al. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic Eastern European population. Neoplasma 63, 107\u2013114 (2016).","journal-title":"Neoplasma"},{"key":"72676_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000149121","volume":"13","author":"Z Yi","year":"1980","unstructured":"Yi, Z. et al. Application of an immunoenzymatic method and an immunoautoradiographic method for a mass survey of nasopharyngeal carcinoma. Intervirology 13, 162\u2013168 (1980).","journal-title":"Intervirology"},{"key":"72676_CR35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000149391","volume":"20","author":"Y Zeng","year":"1983","unstructured":"Zeng, Y. et al. Follow-up studies on Epstein-Barr virus Iga\/Vca antibody-positive persons in Zangwu County, China. Intervirology 20, 190\u2013194 (1983).","journal-title":"Intervirology"},{"key":"72676_CR36","first-page":"665","volume":"4","author":"A Mutirangura","year":"1998","unstructured":"Mutirangura, A. et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 4, 665\u2013669 (1998).","journal-title":"Clin. Cancer Res."},{"key":"72676_CR37","first-page":"1188","volume":"59","author":"YM Lo","year":"1999","unstructured":"Lo, Y. M. et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 59, 1188\u20131191 (1999).","journal-title":"Cancer Res."},{"key":"72676_CR38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa1701717","volume":"377","author":"KCA Chan","year":"2017","unstructured":"Chan, K. C. A. et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. N. Engl. J. Med. 377, 513\u2013522 (2017).","journal-title":"N. Engl. J. Med."},{"key":"72676_CR39","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ijc.26380","volume":"131","author":"Y Liu","year":"2012","unstructured":"Liu, Y. et al. Establishment of vca and ebna1 iga-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China. Int. J. Cancer 131, 406\u2013416 (2012).","journal-title":"Int. J. Cancer"},{"key":"72676_CR40","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/aje\/kws404","volume":"177","author":"Z Liu","year":"2013","unstructured":"Liu, Z. et al. Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in southern China. Am. J. Epidemiol. 177, 242\u2013250 (2013).","journal-title":"Am. J. Epidemiol."},{"key":"72676_CR41","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/annonc\/mdz231","volume":"30","author":"MF Ji","year":"2019","unstructured":"Ji, M. F. et al. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (pro-npc-001) in southern China. Ann. Oncol. 30, 1630\u20131637 (2019).","journal-title":"Ann. Oncol."},{"key":"72676_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25402-z","volume":"12","author":"X Zhou","year":"2021","unstructured":"Zhou, X. et al. A comprehensive risk score for effective risk stratification and screening of nasopharyngeal carcinoma. Nat. Commun. 12, 5189 (2021).","journal-title":"Nat. Commun."},{"key":"72676_CR43","doi-asserted-by":"publisher","first-page":"E5115","DOI":"10.1073\/pnas.1804184115","volume":"115","author":"WKJ Lam","year":"2018","unstructured":"Lam, W. K. J. et al. Sequencing-based counting and size profiling of plasma Epstein-Barr virus dna enhance population screening of nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. USA 115, E5115\u2013E5124 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72676_CR44","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ijc.11130","volume":"105","author":"KH Chan","year":"2003","unstructured":"Chan, K. H. et al. Ebv specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J. Cancer 105, 706\u2013709 (2003).","journal-title":"Int J. Cancer"},{"key":"72676_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1086\/421245","volume":"190","author":"J Fachiroh","year":"2004","unstructured":"Fachiroh, J. et al. Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. J. Infect. Dis. 190, 53\u201362 (2004).","journal-title":"J. Infect. Dis."},{"key":"72676_CR46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/sj.bjc.6603609","volume":"96","author":"MF Ji","year":"2007","unstructured":"Ji, M. F. et al. Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br. J. Cancer 96, 623\u2013630 (2007).","journal-title":"Br. J. Cancer"},{"key":"72676_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1200\/JCO.23.01296","volume":"43","author":"W Chen","year":"2025","unstructured":"Chen, W. et al. Impact of an Epstein-Barr virus serology-based screening program on nasopharyngeal carcinoma mortality: a cluster-randomized controlled trial. J. Clin. Oncol. 43, 22\u201331 (2025).","journal-title":"J. Clin. Oncol."},{"key":"72676_CR48","first-page":"65","volume":"29","author":"MR Chen","year":"1996","unstructured":"Chen, M. R. et al. Use of bacterially expressed GST\/ebna-1 fusion proteins for detection of antibodies in sera from patients with nasopharyngeal carcinoma and healthy donors. Zhonghua Min. Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 29, 65\u201379 (1996).","journal-title":"Zhonghua Min. Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72676-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72676-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72676-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:03:08Z","timestamp":1783555388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72676-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72676"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72676-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6015"}}